News

11 items
  • AI in healthcare at the heart of EU Policymaking

    On 24 September 2025 Professor Liesbet Geris, representing VPH and the in silico medicine community, had the honour of presenting in the SANT Committee of the European Parliament the transformative role of AI and digital technologies in healthcare.

    Discover more
  • Accelerating healthcare through Virtual Human Twins

    Today October 21st, the VPH had the pleasure to attend the European Virtual Human Twins Initiative event in Brussels at the European Commission.

    Discover more
  • VPH Best Thesis Award in In Silico Medicine 2026

    Are you a PhD graduate passionate about in silico medicine? Have you made groundbreaking contributions to the field during your PhD? Here's your chance to shine!

    Discover more
  • The trouble with “AI beats doctors” stories

    AI is transforming healthcare but, beyond the hype, real progress lies in collaboration, not competition.

    Discover more
  • Bias by Design: AI and global health inequity

    The promise of artificial intelligence in global health is grand — but will it deliver for the many, or just the privileged few?

    Discover more
  • In silico medicine in the COVID-19 crisis (Part 3)

    Turning models into action: to face future crises, in silico tools must be timely, transparent, and trusted.

    Discover more
  • How AI is reshaping breast cancer screening

    Despite progress, breast cancer remains deadly worldwide. AI now offers new tools for earlier detection and improved survival.

    Discover more
  • Digital hearts: Transforming pediatric surgery

    In silico heart models help surgeons plan precise pediatric operations. At Boston Children’s, CFD simulations are improving outcomes.

    Discover more
  • In silico medicine in the COVID-19 crisis (Part 2)

    How models allowed to speed up COVID-19 research—optimising vaccines, testing therapies, and simulating immune responses.

    Discover more
  • Decoding multiple sclerosis with in silico medicine

    In silico medicine is unlocking breakthroughs in Multiple Sclerosis, bringing new hope to patients. Discover how...

    Discover more
  • In silico medicine in the COVID-19 crisis (Part 1)

    Five years on from COVID-19, we revisit how in silico models helped detect outbreaks, track transmission, and guide health policies.

    Discover more